Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) (Q66066979)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) |
clinical trial |
Statements
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease (English)
0 references
22 August 2018
0 references
31 May 2022
0 references
760
0 references
50 year
0 references
90 year
0 references